Corporate History

Year Project
2018/08 Obtained EU CE Certification「BL-Cart™ IOL Delivery Cartridge」
2018/07 ICARES(6612-TW) IPO listed at TPEX on 2018.07.18
2018/07 Obtained the NHI Code of 「aspicio™ Preloaded IOL Delivery System」
2018/06 LubriMATRIX obtained US patent US 10,005,854 B2 (Actual patent number to be issued) FUNCTIONALIZED HYDROPHILIC AND LUBRICIOUS POLYMERIC MATRIX AND METHODS OF USING SAME
2018/05 Obtained TFDA approval of「”ICARES” IOL Delivery System」
2017/12 Obtained TFDA approval of「aspicio™ Preloaded IOL Delivery System」
2017/12 Obtained US FDA 510(k) clearance of「pioli™ IOL Delivery System」
2017/08 Obtained EU CE Certification「pioli™ IOL Delivery System」
2017/04 Obtained EU CE Certification「Asqelio ™ Soft Hydrophobic Intraocular Lens」
2016/07 Qualified and passed the Biotech and New Pharmaceutical Investment Plan by the Ministry of Economic Affairs
2015/11 「aspicio™ Soft Hydrophobic Intraocular Lens」has obtained the NHI Code from the National Health Insurance Administration Ministry of Health and Welfare
2015/07 Enterprise Resource Planning (ERP) has been implement
2015/07 Obtained Vietnam approval of「aspicio™ Soft Hydrophobic Intraocular Lens」and 「lioli™ IOL Delivery System」
2015/06 Obtained TFDA approval of 「aspicio™ Soft Hydrophobic Intraocular Lens」
2015/04 First order of IOLs selling to the global market
2015/04 Completed the acquisition of 100% AST Products, Inc. ( a US corporation) as our marketing and strategic partner
2015/04 Obtained US FDA 510(k) clearance of「lioli™ IOL Delivery System」
2015/03 Obtained TFDA approval of「lioli™ IOL Delivery System」
2015/02 Applied US patent for「INJECTOR BARREL AND PLUNGER」
2014/11 Obtained CE Mark approval of「aspicio™ Soft Hydrophobic Intraocular Lens」and 「lioli™ IOL Delivery System」
2014/07 Obtained GMP certification for the manufacturing facility via TFDA
2013/11 Completed prototyping of IOL and its delivery system
2013/06 Qualified and passed the Biotech and New Pharmaceutical Investment Plan by the Ministry of Economic Affairs
2013/04 Obtained certification of ISO 9001/13485 Quality Management Systems
2012/10 Received supplementary for the project of 「Development of High Value Aspheric Intraocular Lens and Its Delivery System for Cataract Surgery」from the Ministry of Economic Affairs
2012/09 IOL manufacturing technology successfully transferred from MBI (Millennium Biomedical, Inc., USA)
2012/06 Received a grant from the R&D Piloting Cooperation Projects between Industries and Academia at the Hsinchu Science Park for the project of 「Development of novel drug eluting intraocular lens」
2012/06 Approved as a biotech and pharma company officially by the Ministry of Economic Affairs
2012/02 Granted certificate from the Public Health Bureau to manufacture medical devices
2012/01 Granted factory registration certificate from the Public Health Bureau
2011/09 Granted certificate from the Public Health Bureau to sell medical devices
2011/07 Founded in Hsinchu, Taiwan, ICARES mainly focuses on development and selling of Intraocular Lens (IOL), IOL Delivery System, and medical devices applied to ophthalmic and nanotechnology fields